Carica papaya Leaf Extract: History
Please note this is an old version of this entry, which may differ significantly from the current revision.
Contributor:

Carica papaya (papaya) leaf extract has been used for a long time in a traditional medicine to treat fever in some infectious diseases such as dengue, malaria, and chikungunya. The development of science and technology has subsequently made it possible to provide evidence that this plant is not only beneficial as an informal medication, but also that it has scientifically proven pharmacological and toxicological activities, which have led to its formal usage in professional health care systems.

  • Carica papaya
  • leaf
  • extract
  • herbal
  • medicine

1. Introduction

Carica papaya (papaw or papaya) is one of the tropical and subtropical trees that are well known for having the entirety of its parts utilized. As a tropical species, this plant grows continuously during winter, although growth slows down and fruit production ceases during the colder months [1]. In Indonesia, the export demands for papaya come from Germany, Hong Kong, Japan, Malaysia, Singapore, Taiwan, and the USA; despite still being high, the export volume decreased from 2009 to 2020 [2]. This could indicate the preservation of this crop becoming less intensive, leading to a reduction in its productivity.

2. Extraction

The extraction of papaya leaf is carried out by means of various methods, from traditional maceration, percolation, and Soxhlet approaches to the use of more advanced instruments such as microwaves and ultrasonic cleaners. Table 1 presents the extraction methods used for papaya leaf along with the solvents involved in these methods. The leaves are mostly extracted using a maceration method that employs 96% ethanol as the solvent. The reason for maceration being the most common method could be that it is simpler and less expensive compared to other methods. The leaf has a soft texture; therefore, it is easier for the solvent to penetrate the leaf cells while extracting the phytoconstituent. However, this method has a disadvantage in terms of the equilibrium state between the outside and inside of the cell since the solvent does not move. This causes the extraction to stop, and the residues of filtrate need to be re-macerated using a new solvent [3][4]. On the other hand, 96% ethanol and water are used as the two most common solvents. The main reason for choosing these solvents is the fact that they have fewer toxic properties compared to others [5]. Most likely, the flavonoid glycoside, as well as alkaloids in a salt form, would be easily extracted from the leaf cells due to their suitable polar character in relation to the solvents. Appropriately in light of the above, these two solvents are the most recommended by the National Agency of Drug and Food Control.
Table 1. The extraction method for papaya leaves along with the solvents used.
Extraction Method Solvents References
Ultrasonic cleaner Methanol
96% ethanol
[6]
[7]
Hot presser Water [8]
Blender Water [9][10][11][12]
Maceration 70% ethanol
96% ethanol
70% methanol
80% methanol
Water
[13][14]
[15][16][17][18][19][20][21][22][23]
[24][25]
[26][27]
[28]
Mixer cold water, hot water, cold ethanol, 70% [29][30]
Microwave methanol, 70% ethanol and water [31]
Soxhlet hexane, acetone, 60% ethanol, 40% ethanol and water [32]

3. Safety

A full safety study was conducted to evaluate papaya leaf extract in both pre-clinical and clinical settings [33]. Male Wistar rats were given up to 1500 mg/kg of a methanolic papaya leaf extract via gavage, which resulted in no observed mortality [34]. An aqueous papaya leaf extract with a dose of 2000 mg/kg BW led to greater LD50 values than those given the methanolic dose in the aforementioned study [35]; meanwhile, there were no mortalities observed when a methanolic papaya leaf extract was administered to Wistar mice in doses of up to 3200 mg/kg [36]. A further study was carried out by giving Wistar rats with a methanolic papaya leaf extract (400 mg/kg bw/d) via gavage for 28 days, it was found that the rats exhibited reduced aspartate aminotransferase activity, enhanced blood urea nitrogen levels, and moderate hyperaemia in the kidney and heart muscles [34]. Another study showed that no extract-related effects were indicated when green papaya leaf extract (up to 2000 mg/kg/day) was administered to Sprague-Dawley rats for 28 days via gavage [37]. Similarly, no adverse effects were shown when Wistar mice were administered a methanolic papaya leaf extract (up to 3200 mg/kg/day) for 60 days [36]. The safety of aqueous papaya leaf extract was evaluated in pregnant Wistar rats via gavage on days 12–18 of gestation with a dose of 60 or 120 mg/kg [38]; deformities were observed in the morphometry of foetuses, while 100% resorption was noted in rats treated with 120 mg/kg of the extract. Other effects of papaya leaf extract on the reproductive system were noted in a study conducted on male Wistar rats [39] given 500 mg/kg BW extract orally for 21 days. This exposure resulted in significant reductions in mean values of sperm count, motility, viability, and serum testosterone concentration, compared to control rats.
Papaya leaf extracts that were mixed with 96% ethanol, followed by partitioning into hexane, ethyl acetate, and water fractions, were evaluated for their cytotoxicity against T47D, a breast cancer cell line, using an MTT assay. The cytotoxicity assay showed that the extract does not interrupt the growth of T47D cells. However, the hexane, ethyl acetate, and water fractions showed reduced viability of T47D cells with IC50 values of 2231.30, 557.33, and 2112.81 µg/mL, respectively. These results showed that the ethanolic extract of papaya leaves and all of its partitions have no potential cytotoxicity in T47D cells due to their high IC50 values [23].
Recently, a juice and standardized aqueous extract of papaya leaf were reported to be well tolerated by adult humans for short durations (<five days), while one randomised controlled trial reported its safe consumption in children (aged 1–12 years). The most common side effects were minor uncomfortable gastrointestinal feelings. Hepatotoxicity and reproductive toxicity were concerns in relation to long-term use, which was supported by in vivo animal studies. Some unfavourable herb-drug interactions were indicated with metformin, glimepiride, digoxin, ciprofloxacin, and artemisinin. In conclusion, papaya leaf consumption by adults is most likely safe for short-term use but should be carefully managed when it is given to pregnant women and people with liver impairments. Furthermore, potential herb-drug interactions could occur with oral hypoglycaemic agents, P-glycoprotein substrates, and antibiotics with cation-chelating properties [40]. As previously mentioned, a papaya leaf extract produced by Sido Muncul showed non-sub-chronic toxicity even for long periods of consumption when it was evaluated in an animal study.

This entry is adapted from the peer-reviewed paper 10.3390/molecules26226922

References

  1. Allan, P. November. Carica papaya responses under cool subtropical growth conditions. Int. Symp. Trop. Subtrop. Fruits 2000, 575, 757–763.
  2. Kinding, D.P.N. The financial eligibility of Indonesian calina/ california (Carica papaya L.) farm industry. PJSE 2021, 1, 24–33.
  3. Mohammad Azmin, S.N.H.; Abdul Manan, Z.; Wan Alwi, S.R.; Chua, L.S.; Mustaffa, A.A.; Yunus, N.A. Herbal processing and extraction technologies. Sep. Purif. Rev. 2016, 45, 305–320.
  4. Hariono, M.; Rollando, R.; Karamoy, J.; Hariyono, P.; Atmono, M.; Djohan, M.; Wiwy, W.; Nuwarda, R.; Kurniawan, C.; Salin, N.; et al. Bioguided fractionation of local plants against matrix metalloproteinase9 and its cytotoxicity against breast cancer cell models: In silico and in vitro study. Molecules 2020, 25, 4691.
  5. Do, Q.D.; Angkawijaya, A.E.; Tran-Nguyen, P.L.; Huynh, L.H.; Soetaredjo, F.E.; Ismadji, S.; Ju, Y.H. Effect of extraction solvent on total phenol content, total flavonoid content, and antioxidant activity of Limnophila aromatica. J. Food Drug Anal. 2014, 22, 296–302.
  6. Fauziah, L.; Wakidah, M. Extraction of papaya leaves (Carica papaya L.) using ultrasonic cleaner. EKSAKTA JSDA 2019, 19, 35–45.
  7. Utama, S.Y.A. The effect of papaya leaf extract (Carica papaya L.) to the bleeding time on mice with thrombocytopenia. IJND 2018, 6, 133–138.
  8. Kumar, M.; Sharma, P.C.; Verma, A.K.; Sharma, A. Utilization of Carica papaya Herbal Leaf Extract for Preparation of a Nutraceutical Functional Beverage. Chem. Sci. Rev. Lett. 2020, 9, 39–49.
  9. Permadi, M.A.; Lubis, R.A.; Syawaludin, S.; Pasaribu, N.S. Utilization of papaya leaves (Carica papaya L.) to control onion pest Spodoptera exigua (lepidoptera: Noctuidae) lepidoptera (noctuidae). Biolink 2020, 7, 1–7.
  10. Lonkala, S.; Reddy, A.R.N. Antibacterial activity of Carica papaya Leaves and Allium sativum cloves alone and in combination against multiple strains. Pharmacogn. J. 2019, 11, 600–602.
  11. Nurjannah, N.; Hamidah, A.; Anggereini, E. Effect of Carica papaya Leaf Juice on Hematology of Mice (Mus musculus) with Anemia. Biosaintifika 2017, 9, 417–422.
  12. Hussain, S.M.; Sohrab, M.; Al-Mahmood, A.K.; Shuayb, M.; Al-Mansur, M.; Hasan, C. Clinical use of Carica papaya leaf extract in chemotherapy induced thrombocytopaenia. Int. J. Clin. Exp. Med. 2017, 10, 3752–3756.
  13. Megantara, S.; Mustarichie, R. Formulation of black hair dyes in the form of sticks from papaya seed extracts and powder. Int. Res. J. Pharm. 2018, 9, 69–74.
  14. Pertiwi, D.; Hafiz, I.; Salma, R. Antibacterial Activity of Gel of Ethanol Extract of Papaya Leaves (Carica papaya L.) againts Propionobacterium acnes. Indones. J. Pharm. Clinical Res. 2019, 2, 01–06.
  15. Ugo, N.J.; Ade, A.R.; Joy, A.T. Nutrient Composition of Carica papaya Leaves Extracts. J. Food Nutr. Sci. Res. 2019, 2, 274–282.
  16. Kurniawan, B.; Rapina, R.; Sukohar, A.; Nareswari, S. Effectiveness of the pepaya leaf (Carica papaya L.) ethanol extract as larvacide for Aedes aegypti Instar III. J. Major. 2015, 4, 76–84.
  17. Haldar, S.; Mohapatra, S.; Singh, R.; Katiyar, C.K. Isolation and quantification of bioactive Carpaine from Carica papaya L. and its commercial formulation by HPTLC densitometry. J. Liq. Chromatogr. Relat. Technol. 2020, 43, 388–393.
  18. Nugroho, B.H.; Citrariana, S.; Sari, I.N.; Oktari, R.N. Formulation and evaluation of SNEDDS (Self Nano-emulsifying Drug Delivery System) of papaya leaf extracts (Carica papaya L.) as an analgesic. Pharm. Sci. J. 2017, 13, 77–85.
  19. Sari, C.M.A.; Andriani, D.; Wahyudi, D. Optimization of HPMC dan Carbopol combination in formulation of papaya seeds ethanolic extract gel (Carica papaya L.) and its antibacterial activity against Escherichia coli. JIFI 2020, 3, 241–252.
  20. Sugito, S.; Suwandi, E. Effectivity of papaya leaf ethanolic extract (Carica papaya L.) toward the bacterial growth of Escherichia coli using diffusion method. J. Lab. Khatulistiwa. 2017, 1, 21–25.
  21. Gredi, J. Analgesic effectivity of Chitosan-Papaya Leaf Ethanolic Extract Nanoparticle (Carica papaya L.) in male white mice (Mus Mucculus). Doctoral Dissertation, Tanjungpura University, Pontianak, Indonesia, 2015.
  22. Payangka, J.; Risma, R.; Wibowo, P. The influence of papaya leaf extract (Carica papaya) toward Aedes agypti INSTAR III mosquito larvae mortality. Med. Health Sci. J. 2019, 3, 7–16.
  23. Yuliani, R.; Syahdeni, F. Ethanolic extract of papaya leaves (Carica papaya) and its fractions have no potential cytotoxicity on T47D Cells. Pharmacon JFI 2020, 17, 17–23.
  24. Tewari, B.B.; Subramanian, G.; Gomathinayagm, R. Antimicrobial properties of Carica papaya (Papaya) different leaf extract against E. coli, S. aureus and C. albicans. Am. J. Pharmacol. Pharmacother. 2014, 1, 025–039.
  25. Kamilla, L.; Tumpuk, S.; Salim, M. Anti-Inflammatory of papaya leaf extract (Carica papaya L.) towards membrane stabilization of red blood cells. JKP 2021, 15, 1–7.
  26. Nariya, A.; Jhala, D. Pharmacognostic study of Carica papaya leaf extract as inhibitors of reactive oxygen species. Int. Res. J. Pharm. 2017, 8, 13–17.
  27. Hariono, M.; Hariyono, P.; Dwiastuti, R.; Setyani, W.; Yusuf, M.; Salin, N.; Wahab, H. Potential SARS-CoV-2 3CLpro inhibitors from chromene, flavonoid and hydroxamic acid compound based on FRET assay, docking and pharmacophore studies. RECHEM 2021, 3, 100195.
  28. Anwar, T.; Qureshi, H.; Parveen, N.; Bashir, R.; Qaisar, U.; Munazir, M.; Yasmin, S.; Basit, Z.; Mahmood, R.T.; Nayyar, B.G.; et al. Evaluation of bioherbicidal potential of Carica papaya leaves. Braz. J. Biol. Sci. 2019, 80, 565–573.
  29. Arunkumar, S.; Muthuselvam, M. Analysis of phytochemical constituents and antimicrobial activities of Aloe vera L. against clinical pathogens. World J. Agric. Res. 2009, 5, 572–576.
  30. Liana, Y. Comparative effectiveness of papaya leaf stew (Carica papaya L.) with turmeric acid (Curcuma domestica val-Tamarindus indica) against primary dysmenorrhea. SJM 2018, 1, 120–127.
  31. Nisa, F.Z.; Astuti, M.; Haryana, S.M.; Murdiati, A. Antioxidant activity and total flavonoid of Carica papaya L. leaves with different varieties, maturity and solvent. Agritech 2019, 39, 54–59.
  32. Singh, V.; Goyal, I.; Saini, A.; Chandra, R. Studying the effect of Carica papaya leaf extract on the shelf life of platelets. IJSR 2017, 6, 2319–7064.
  33. Safety Assessment of Carica papaya (papaya)-Derived Ingredients as Used in Cosmetics. Available online: https://www.cir-safety.org/sites/default/files/Papaya.pdf (accessed on 9 November 2021).
  34. Nkeiruka, U.E.; Chinaka, N.O. Anti-fertility effects of Carica papaya linn: Methanol leaf extracts in male wistar rats. J. Pharmacol. Toxicol. 2013, 8, 35–41.
  35. Halim, S.Z.; Abdullah, N.R.; Afzan, A.; Rashid, B.A.; Jantan, I.; Ismail, Z. Acute toxicity study of Carica papaya leaf extract in Sprague Dawley rats. J. Med. Plant Res. 2011, 5, 1867–1872.
  36. Peristiowati, Y.; Puspitasari, Y. Acute and subchronic toxicity tests of papaya leaf (Carica papaya Linn.) methanol extract on wistar strainwhite mice. J. Appl. Environ. Biol. Sci. 2017, 7, 9–14.
  37. Afzan, A.; Abdullah, N.R.; Halim, S.Z.; Rashid, B.A.; Semail, R.H.R.; Abdullah, N.; Jantan, I.; Muhammad, H.; Ismail, Z. Repeated dose 28-days oral toxicity study of Carica papaya L. leaf extract in Sprague Dawley rats. Molecules 2012, 17, 4326–4342.
  38. Ekong, M.B.; Akpan, M.U.; Ekanem, T.B.; Akpaso, M.I. Morphometric malformations in fetal rats following treatment with aqueous leaf extract of Carica papaya. Asian J. Med. Sci. 2011, 2, 18–22.
  39. Akinloye, O.O.; Morayo, O.M. Evaluation of andrological indices and testicular histology following chronic administration of aqueous extract of Carica papaya leaf in Wistar rat. Afr. J. Pharmacy Pharmacol. 2010, 4, 252–255.
  40. Lim, X.Y.; Chan, J.S.W.; Japri, N.; Lee, J.C.; Tan, T.Y.C. Carica papaya L. Leaf: A Systematic Scoping Review on Biological Safety and Herb-Drug Interactions. eCAM 2021, 2021, 1–21.
More
This entry is offline, you can click here to edit this entry!
Video Production Service